Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Binder

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|January 23, 2024
Amyloid Burden Correlates with Electrocardiographic Findings in Patients with Cardiac Amyloidosis-Insights from Histology and Cardiac Magnetic Resonance ImagingFranz Duca, René Rettl, Christina Kronberger, et al.
Journal of Clinical Medicine|January 8, 2025
His108Arg Transthyretin Amyloidosis-Shedding Light on a Distinctively Malignant VariantChristina Binder, Lena Marie Schmid, Christina Kronberger, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 6, 2024
Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort studyMichael Poledniczek, Christina Kronberger, Robin Willixhofer, et al.
Journal of Clinical Medicine|October 16, 2024
Leukocyte Indices as Markers of Inflammation and Predictors of Outcome in Heart Failure with Preserved Ejection FractionMichael Poledniczek, Christina Kronberger, Luca List, et al.
Journal of Clinical Medicine|May 8, 2020
Machine Learning Enables Prediction of Cardiac Amyloidosis by Routine Laboratory Parameters: A Proof-of-Concept StudyAsan Agibetov, Benjamin Seirer, Theresa-Marie Dachs, et al.
Journal of Clinical Medicine|May 14, 2025
Cardiopulmonary Exercise Testing Correlates with Quantitative Left Ventricular [<sup>99m</sup>Tc]-DPD Uptake in Transthyretin Amyloid CardiomyopathyNikita Ermolaev, René Rettl, Robin Willixhofer, et al.
Journal of Clinical Medicine|April 16, 2020
Hemodynamic Profiles and Their Prognostic Relevance in Cardiac AmyloidosisFranz Duca, Amir Snidat, Christina Binder, et al.
Reviews in Cardiovascular Medicine|March 31, 2025
Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac AmyloidosisNikita Ermolaev, Robin Willixhofer, Christoph Krall, et al.
Panminerva Medica|February 15, 2023
Cardiac amyloidosis: a significant blind spot of the H2FPEF scoreFranz Duca, Rene Rettl, Christina Binder, et al.
European Radiology|July 16, 2025
Serial extracellular volume quantification using cardiac magnetic resonance imaging in transthyretin amyloidosis patients treated with tafamidisFranz Duca, Michael Poledniczek, Christina Kronberger, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|January 23, 2024
Amyloid Burden Correlates with Electrocardiographic Findings in Patients with Cardiac Amyloidosis-Insights from Histology and Cardiac Magnetic Resonance ImagingFranz Duca, René Rettl, Christina Kronberger, et al.
Journal of Clinical Medicine|January 8, 2025
His108Arg Transthyretin Amyloidosis-Shedding Light on a Distinctively Malignant VariantChristina Binder, Lena Marie Schmid, Christina Kronberger, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 6, 2024
Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort studyMichael Poledniczek, Christina Kronberger, Robin Willixhofer, et al.
Journal of Clinical Medicine|October 16, 2024
Leukocyte Indices as Markers of Inflammation and Predictors of Outcome in Heart Failure with Preserved Ejection FractionMichael Poledniczek, Christina Kronberger, Luca List, et al.
Journal of Clinical Medicine|May 8, 2020
Machine Learning Enables Prediction of Cardiac Amyloidosis by Routine Laboratory Parameters: A Proof-of-Concept StudyAsan Agibetov, Benjamin Seirer, Theresa-Marie Dachs, et al.
Journal of Clinical Medicine|May 14, 2025
Cardiopulmonary Exercise Testing Correlates with Quantitative Left Ventricular [<sup>99m</sup>Tc]-DPD Uptake in Transthyretin Amyloid CardiomyopathyNikita Ermolaev, René Rettl, Robin Willixhofer, et al.
Journal of Clinical Medicine|April 16, 2020
Hemodynamic Profiles and Their Prognostic Relevance in Cardiac AmyloidosisFranz Duca, Amir Snidat, Christina Binder, et al.
Reviews in Cardiovascular Medicine|March 31, 2025
Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac AmyloidosisNikita Ermolaev, Robin Willixhofer, Christoph Krall, et al.
Panminerva Medica|February 15, 2023
Cardiac amyloidosis: a significant blind spot of the H2FPEF scoreFranz Duca, Rene Rettl, Christina Binder, et al.
European Radiology|July 16, 2025
Serial extracellular volume quantification using cardiac magnetic resonance imaging in transthyretin amyloidosis patients treated with tafamidisFranz Duca, Michael Poledniczek, Christina Kronberger, et al.
Pageof 10